FDA approves NeuRx diaphragm pacing system for use in spinal cord- injured patients

The U.S. Food and Drug Administration (FDA) has approved the NeuRx Diaphragm Pacing System (DPS) for spinal cord-injured patients who are dependent on ventilators for breathing. The light-weight, battery-powered electronic DPS allows patients to breathe and speak more naturally, while eliminating the need for a power source and concern over power outages.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news133008368.html">FDA approves NeuRx diaphragm pacing system for use in spinal cord- injured patients</a></p> <p>The U.S. Food and Drug Administration (FDA) has approved the NeuRx Diaphragm Pacing System (DPS) for spinal cord-injured patients who are dependent on ventilators for breathing. The light-weight, battery-powered electronic DPS allows patients to breathe and speak more naturally, while eliminating the need for a power source and concern over power outages.</p>